Combined Erlotinib and PF-03084014 treatment contributes to synthetic lethality in head and neck squamous cell carcinoma.
Yang ZhengZhao WangXu DingYibo DongWei ZhangWei ZhangYi ZhongWenyi GuYunong WuXiaomeng SongPublished in: Cell proliferation (2017)
These results suggested that concomitant inhibition of the Notch1 and EGFR pathways represented a rational strategy for promoting apoptosis in HNSCC and overcoming treatment resistance.